This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
619 |
4. Check minimum number of eventsNone |
619 |
5. Include endpointsNone |
619 |
6. Filter based on genotype QC (FinnGen only) |
619 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Disorders in reading
based on the number of shared cases.
Similar with more cases:
- Specific development disorders of scholastic skills
- Speech and linguistic disorders, excluding more controls
- Speech and linguistic disorders
- Disorders of psychological development
- Any mental disorder
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 619 | 314 | 305 |
| Unadjusted period prevalence (%) | 0.12 | 0.11 | 0.13 |
| Median age at first event (years) | 14.59 | 17.17 | 11.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 534
- Matched controls
- 5341
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F81.0
ICD-10 Finland
Specific reading disorder
8860.8
323.0
494
7
F81.1
ICD-10 Finland
Specific spelling disorder
308.2
79.8
79
*
F90.0
ICD-10 Finland
Disturbance of activity and attention
6.7
45.7
128
240
3150A
ICD-9 Finland
Specific delays in development, Specific reading disorder
+∞
45.5
43
*
N06BA04
ATC
methylphenidate; oral
5.9
31.3
94
187
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.6
30.6
167
601
F80.1
ICD-10 Finland
Expressive language disorder
13.0
29.6
53
45
XA800
NOMESCO Finland
Neuropsychological investigation
5.5
24.9
78
162
Z2445
NOMESCO Finland
Psychologist
4.3
24.8
100
271
N05AH04
ATC
quetiapine; oral
3.1
23.6
155
622
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
12.3
21.1
38
33
F80.2
ICD-10 Finland
Receptive language disorder
10.7
20.7
40
40
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
10.4
19.4
38
39
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.5
19.3
72
179
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
13.0
18.3
32
26
ZY010
NOMESCO Finland
Hospital outpatient
3.6
18.2
89
282
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.8
18.2
136
582
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
23.8
17.9
25
11
3152A
ICD-9 Finland
Specific delays in development, Other specific learning difficulties
+∞
17.8
17
*
N06AX16
ATC
venlafaxine; oral
3.1
16.9
104
390
N06AX11
ATC
mirtazapine; oral
2.5
16.7
158
769
N06AB04
ATC
citalopram; systemic
2.9
15.8
107
426
N06AX21
ATC
duloxetine; oral
3.8
15.0
66
191
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.1
14.6
87
318
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.9
14.4
97
384
Z13.4
ICD-10 Finland
Special screening examination for certain developmental disorders in childhood
77.1
13.6
15
*
Z2446
NOMESCO Finland
Social worker
2.9
13.5
88
339
Z2221
NOMESCO Finland
Medical doctor
2.2
13.4
166
907
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.3
13.2
69
230
Z3231
NOMESCO Finland
Registered nurse
2.2
13.0
172
963
F82
ICD-10 Finland
Specific developmental disorder of motor function
6.9
12.7
31
47
N06AB10
ATC
escitalopram; oral
2.3
12.5
140
723
N06AB03
ATC
fluoxetine; oral
2.9
12.2
77
291
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
12.2
120
584
N05AX08
ATC
risperidone; systemic
3.4
12.0
59
187
N06AB06
ATC
sertraline; oral
2.7
12.0
86
351
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.4
11.8
57
179
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
11.5
162
922
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.4
11.4
56
178
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
11.1
68
252
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.8
10.9
46
129
F34.1
ICD-10 Finland
Dysthymia
5.0
10.9
34
71
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
6.6
10.8
27
43
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.7
10.7
46
131
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.9
10.7
43
116
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
10.5
289
2091
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.1
10.5
59
206
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.4
10.5
51
161
K02.1
ICD-10 Finland
Caries of dentine
1.9
10.3
369
2905
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.2
10.1
54
183
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
4.0
10.0
40
107
SPAT1283
SPAT
Restricted health certificate
1.9
10.0
196
1258
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.6
10.0
28
52
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
9.9
174
1069
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
10.9
9.8
18
17
S18
ICPC
Laceration/cut
1.9
9.7
171
1052
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
9.7
65
256
ZXE00
NOMESCO Finland
One hour or less
1.8
9.6
205
1350
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
9.5
275
1995
N05BA04
ATC
oxazepam; oral
2.2
9.4
105
538
N06AG02
ATC
moclobemide; oral
5.9
9.3
25
44
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.5
9.2
43
132
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.8
9.2
313
2380
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.7
9.2
64
257
A05
ICPC
Feeling ill
2.3
9.1
90
433
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.8
9.1
58
221
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
5.4
9.0
26
50
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
6.3
8.7
22
36
N03AX09
ATC
lamotrigine; oral
3.2
8.7
44
144
WX110
NOMESCO Finland
Local anesthesy
1.8
8.6
399
3307
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.6
8.6
21
33
Z3226
NOMESCO Finland
Physiotherapist
2.1
8.5
108
580
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.1
8.5
99
516
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
8.5
195
1301
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
8.4
50
183
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
6.4
8.4
21
34
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.3
8.4
85
414
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
8.2
89
448
M54.5
ICD-10 Finland
Low back pain
1.8
8.1
156
980
N05CF01
ATC
zopiclone; oral
2.1
8.1
94
487
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
2.0
8.1
121
694
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.5
8.1
36
107
R06.0
ICD-10 Finland
Dyspnoea
2.2
8.0
89
452
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
8.0
416
3525
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
6.8
7.9
19
29
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
7.9
259
1912
N06AX12
ATC
bupropion; oral
2.6
7.9
57
234
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.3
7.9
39
126
A02BC02
ATC
pantoprazole; systemic
1.7
7.8
215
1508
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
7.8
53
210
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
7.8
323
2541
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
7.8
173
1137
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.6
7.7
33
95
F40.1
ICD-10 Finland
Social phobias
3.5
7.7
35
106
L12
ICPC
Hand/finger symptom/complaint
2.0
7.7
104
572
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
6.9
7.6
18
27
R03AC03
ATC
terbutaline; inhalant
2.3
7.6
74
354
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.2
7.6
76
368
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
7.6
59
253
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
3.5
7.6
34
102
N06BA09
ATC
atomoxetine; oral
10.2
7.6
14
14
ZXA05
NOMESCO Finland
Left side
2.1
7.6
84
427
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
7.5
68
315
E66.8
ICD-10 Finland
Other obesity
3.6
7.4
32
93
WX290
NOMESCO Finland
Other blockade of nerve
1.7
7.4
300
2333
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
7.3
64
290
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.0
7.2
41
145
N06AA12
ATC
doxepin; systemic
5.2
7.2
21
42
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.0
7.2
95
519
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.5
7.1
53
222
N05AH03
ATC
olanzapine; systemic
2.6
7.1
50
203
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.7
7.0
29
82
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
6.9
93
509
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.7
6.9
45
175
R03AC02
ATC
salbutamol; inhalant
1.6
6.9
265
2018
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.8
6.9
27
73
-
ICD-10 Finland
NA
6.8
6.9
16
24
A03
ICPC
Fever
1.8
6.8
147
951
KMAK
NOMESCO Finland
NA
1.6
6.8
269
2056
ZXA10
NOMESCO Finland
Bilateral
2.1
6.8
81
424
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.5
6.8
53
228
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
6.7
90
496
D06
ICPC
Abdominal pain localized other
2.4
6.7
55
242
N06AX22
ATC
agomelatine; oral
4.1
6.7
24
60
UJF32
NOMESCO Finland
Coloscopy
2.2
6.6
70
349
ZYC01
NOMESCO Finland
Remote contact by phone
2.8
6.6
42
160
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.7
6.5
26
72
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.5
358
2971
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.4
6.5
29
88
K04.08
ICD-10 Finland
Other specified pulpit
2.4
6.4
56
253
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
6.4
76
396
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.0
6.4
34
117
WX002
NOMESCO Finland
Sedation and analgesia
2.1
6.4
70
354
J01AA02
ATC
doxycycline; systemic
1.6
6.4
260
1994
N03AG01
ATC
valproic acid; systemic, rectal
2.6
6.4
44
176
SPAT1307
SPAT
Psychosocial counselling and guidance
2.0
6.3
80
430
ZXD20
NOMESCO Finland
Day surgery
2.2
6.3
61
292
RS210
NOMESCO Finland
NA
11.2
6.3
11
10
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
6.2
130
831
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
4.8
6.2
19
41
SPAT1310
SPAT
Counselling related to known health issue
1.6
6.1
173
1204
J01DB01
ATC
cefalexin; oral
1.7
6.1
403
3473
R02
ICPC
Shortness of breath/dyspnoea
2.2
6.0
57
271
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
6.1
6.0
15
25
N06BA12
ATC
lisdexamfetamine; oral
6.1
6.0
15
25
P06
ICPC
Sleep disturbance
2.2
6.0
61
299
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40761535) Cells panel - Urine sediment
70
215
3.54
19.35
2.7
3.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
288
1786
2.15
18.90
6.7
5.6
umol/l
10.0
10.7
0.56
273
1670
(3011397) Hemoglobin [Presence] in Urine by Test strip
186
969
2.31
18.81
3.5
3.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
172
885
2.31
17.78
2.6
1.8
%
1.6
1.4
2.67
158
819
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
85
311
3.01
17.62
5.3
4.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
250
1514
2.09
17.01
4.6
3.3
u/l
33.4
30.4
0.26
238
1438
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
167
865
2.27
16.89
2.2
2.3
u/l
156.3
327.3
1.27
153
832
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
405
2968
2.05
15.80
7.3
6.1
u/l
80.9
83.9
0.62
388
2786
(3019150) Specific gravity of Urine by Refractometry
181
1002
2.14
15.32
3.9
3.0
kg/l
1.0
1.0
0.83
14
139
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
265
1694
1.99
15.07
11.4
7.5
mmol/l
1.2
1.2
0.48
233
1480
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
468
3649
2.16
15.04
4.3
3.7
pmol/l
14.3
14.4
0.43
452
3366
(3028707) Methadone [Presence] in Urine by Screen method
84
333
2.76
14.96
3.8
2.9
—
—
—
0
0
(3015736) pH of Urine
268
1738
1.96
14.46
3.4
2.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
246
1560
1.96
14.09
11.0
7.5
mmol/l
1.2
1.2
0.06
227
1454
(3023103) Potassium [Moles/volume] in Serum or Plasma
535
4457
2.48
13.83
15.0
9.2
mmol/l
3.9
3.9
0.89
523
4291
(3015377) Calcium [Moles/volume] in Serum or Plasma
184
1069
2.03
13.43
2.5
2.7
mmol/l
2.4
2.4
0.36
167
977
(3019550) Sodium [Moles/volume] in Serum or Plasma
533
4450
2.42
13.41
15.0
9.2
mmol/l
139.7
139.6
1.01
522
4305
(3024561) Albumin [Mass/volume] in Serum or Plasma
227
1423
1.94
13.28
7.2
5.6
g/l
38.1
38.1
0.05
212
1334
(3044889) 12 lead EKG panel
336
2400
1.87
13.07
3.1
2.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
374
2784
1.87
12.56
12.2
9.1
e9/l
4.0
3.8
0.80
329
2418
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
475
3838
2.02
12.25
3.7
2.7
mmol/l
5.7
5.5
1.56
451
3556
(3001604) Monocytes [#/volume] in Blood
339
2459
1.84
12.25
9.1
7.0
e9/l
0.6
0.5
0.66
292
2146
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
122
632
2.16
11.95
3.6
2.9
e6/l
0.9
0.6
0.43
72
333
(3006315) Basophils [#/volume] in Blood
338
2466
1.82
11.82
9.1
7.0
e9/l
0.0
0.0
0.14
293
2150
(3013115) Eosinophils [#/volume] in Blood
345
2539
1.81
11.66
10.7
7.5
e9/l
0.2
0.2
0.78
303
2264
(3009508) Creatinine [Moles/volume] in Urine
186
1134
1.92
11.54
4.0
3.7
mmol/l
9.1
9.1
0.07
173
1010
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
509
4256
2.10
11.37
5.0
4.1
mu/l
1.8
2.0
0.51
489
4010
(3018418) pH of Serum or Plasma
160
932
1.97
11.34
4.2
3.8
ph
7.4
7.4
0.77
13
174
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
190
1177
1.89
11.18
1.7
1.5
pmol/l
97.1
97.1
0.01
106
642
(3020630) Protein [Mass/volume] in Serum or Plasma
45
149
3.18
11.00
1.7
3.0
g/l
66.6
66.3
0.08
39
141
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
208
1338
1.84
10.79
4.1
3.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
176
1082
1.88
10.51
4.1
3.3
e6/l
0.2
0.2
0.15
135
802
(3019198) Lymphocytes [#/volume] in Blood
344
2590
1.74
10.20
9.4
6.9
e9/l
2.1
2.0
0.12
304
2313
(3018095) Leukocytes [#/volume] in Urine
223
1498
1.76
9.83
4.7
3.8
e6/l
61.3
69.2
0.06
147
968
(3013707) Erythrocyte sedimentation rate by Westergren method
396
3121
1.75
9.79
4.5
3.7
mm/h
8.6
7.4
1.44
373
2906
(40758558) Short blood count panel - Blood
192
1237
1.80
9.74
11.4
7.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
175
1106
1.81
9.42
4.1
3.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
159
979
1.84
9.30
2.6
2.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
136
799
1.90
9.21
2.9
2.8
e6/l
8.8
7.7
0.25
116
705
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
247
1757
1.68
8.57
3.0
2.7
nmol/l
62.7
69.0
3.69
234
1650
(3003396) Base excess in Arterial blood by calculation
58
252
2.44
8.52
7.6
11.4
mmol/l
0.7
0.4
0.20
39
198
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
43
161
2.80
8.50
1.7
1.9
ug/l
6.1
6.7
0.07
37
146
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
553
4911
2.18
8.45
14.4
9.5
mg/l
21.7
20.5
0.38
453
3594
(3013826) Glucose [Moles/volume] in Serum or Plasma
308
2327
1.64
8.39
6.9
4.9
mmol/l
6.2
6.3
0.18
283
2084
(3033658) Prothrombin time (PT) actual/Normal
164
1048
1.77
8.38
6.9
4.8
%
94.7
92.5
0.60
159
1030
(3035350) Ketones [Presence] in Urine by Test strip
291
2169
1.64
8.35
3.6
3.0
estimate
0.0
0.0
0.00
30
440
(3019309) Folate [Moles/volume] in Red Blood Cells
78
390
2.14
8.24
1.6
1.6
nmol/l
1099.7
1101.3
0.01
64
312
(3003338) MCHC [Mass/volume]
540
4787
2.00
7.77
20.9
11.6
g/l
335.3
335.3
0.04
535
4748
(3023368) Bacteria identified in Blood by Culture
127
768
1.82
7.75
4.4
3.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
415
3417
1.65
7.72
4.7
3.5
mmol/mol
37.2
37.2
0.02
398
3251
(1001926) Buprenorphine [Presence] in Urine by Screen method
104
591
1.91
7.70
3.4
2.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
558
5019
2.13
7.49
11.6
7.7
u/l
33.6
28.2
0.91
546
4860
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
70
349
2.13
7.44
2.2
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
286
2175
1.59
7.23
4.9
4.1
estimate
0.0
0.0
0.50
36
465
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
167
1121
1.67
6.98
3.0
2.7
u/l
54.8
56.0
0.12
152
1043
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
69
351
2.09
6.97
2.2
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
82
445
1.97
6.93
2.2
2.2
mmol/l
2.4
2.4
0.39
68
377
(3009261) Glucose [Presence] in Urine by Test strip
287
2201
1.57
6.89
3.7
3.0
estimate
0.0
0.0
0.00
36
445
(3037467) Urinalysis macro (dipstick) panel - Urine
374
3048
1.57
6.85
4.7
3.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
175
1197
1.64
6.77
4.3
3.3
e6/l
16.0
45.6
2.37
133
908
(3011288) Drugs identified in Urine by Screen method
90
511
1.89
6.66
5.2
3.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
114
703
1.76
6.44
3.0
2.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
302
2368
1.54
6.41
10.4
7.2
%
8.2
8.2
0.07
283
2260
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
153
1032
1.64
6.19
2.2
2.7
mg/l
2.4
2.6
0.54
136
899
(44816559) Phosphatidylethanol [Mass/volume] in Blood
38
158
2.50
6.16
1.4
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
103
628
1.77
6.04
4.1
3.0
e6/l
3.5
3.3
0.04
55
331
(3012095) Magnesium [Moles/volume] in Serum or Plasma
93
550
1.81
6.04
10.4
6.6
mmol/l
0.8
0.8
0.06
87
525
(3006504) Eosinophils/100 leukocytes in Blood
298
2352
1.51
6.00
10.0
7.0
%
2.9
2.9
0.06
280
2231
(3002385) Erythrocyte distribution width [Ratio]
509
4526
1.70
5.97
18.9
12.0
%
13.3
13.1
1.94
503
4444
(3000764) Benzodiazepines [Presence] in Urine
118
753
1.70
5.88
3.3
2.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
29
108
2.77
5.84
1.9
2.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
309
2467
1.50
5.83
9.6
6.7
%
54.2
54.0
0.11
290
2360
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
92
548
1.80
5.83
1.4
1.5
pmol/l
456.2
13646060.4
0.50
81
491
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
20
5.58
5.82
5.4
4.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
288
2273
1.50
5.71
10.6
7.2
%
0.7
0.7
0.31
270
2168
(3028300) Cannabinoids [Presence] in Urine
118
759
1.69
5.70
3.6
2.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
136
908
1.64
5.69
3.2
2.6
mg/l
0.8
1.0
0.38
91
616
(3027944) Amphetamines [Presence] in Urine
116
745
1.69
5.63
3.3
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
117
755
1.68
5.58
3.3
2.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
220
1648
1.52
5.57
10.3
7.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
310
2501
1.48
5.42
9.7
6.8
%
31.5
31.6
0.08
289
2390
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
39
175
2.31
5.38
1.4
1.3
—
—
—
0
0
(4010399)
45
215
2.18
5.35
1.6
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
53
270
2.05
5.35
1.1
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
88
531
1.77
5.33
4.4
4.1
s
29.3
30.2
0.85
88
522
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
144
1003
1.57
5.00
2.5
2.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
30
124
2.49
4.96
4.7
8.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
97
614
1.69
4.95
3.5
3.7
mg/l
65.6
86.5
0.35
73
444
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
449
3937
1.51
4.93
9.8
7.3
ml/min/173m2
105.2
103.2
1.13
342
2994
(3022217) INR in Platelet poor plasma by Coagulation assay
44
216
2.12
4.90
13.7
9.5
inr
1.0
1.2
—
6
51
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
71
412
1.82
4.90
2.5
2.5
u/l
25.9
155.4
0.56
63
344
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
47
237
2.06
4.89
2.0
2.1
ml/min/173m2
86.3
87.2
0.05
13
82
(3020682) Albumin/Creatinine [Ratio] in Urine
100
643
1.66
4.81
3.6
4.6
mg/mmol
11.0
13.4
0.23
73
466
(3026493) Urate [Moles/volume] in Serum or Plasma
110
730
1.62
4.67
4.8
2.8
umol/l
4389.1
4285.4
0.01
101
672
(3005719) IgG [Mass/volume] in Serum or Plasma
70
412
1.79
4.61
5.3
2.6
g/l
9.2
10.2
1.65
60
383
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
142
1003
1.54
4.61
2.4
2.3
ng/l
60.0
33.9
0.35
52
396
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
81
499
1.72
4.56
2.1
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
465
4141
1.49
4.43
3.8
3.0
mmol/l
2.9
2.8
0.20
447
3922
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
251
2001
1.43
4.39
4.5
3.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
43
220
2.03
4.32
2.8
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
22
4.60
4.31
1.6
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
113
769
1.57
4.30
3.1
2.8
mosm/kgh2o
608.4
594.2
0.18
93
674
(3044640) Blood type and Crossmatch panel - Blood
171
1275
1.47
4.24
2.7
2.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
74
454
1.72
4.23
2.8
2.6
%
20.6
24.9
1.91
65
400
(3032080) INR in Blood by Coagulation assay
148
1074
1.50
4.20
7.0
4.8
inr
1.1
1.1
0.22
33
387
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
443
3924
1.45
4.20
3.3
2.7
mmol/l
1.3
1.2
1.93
423
3737
(3022621) pH of Urine by Test strip
43
223
2.00
4.17
3.3
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
83
529
1.66
4.12
1.7
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
70
426
1.73
4.12
14.9
9.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
22
86
2.62
4.09
1.3
2.2
—
—
—
0
0
(4198724)
21
81
2.65
4.01
6.1
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
94
623
1.60
4.00
1.4
1.3
nmol/l
21.0
18.9
0.74
83
546
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
210
1645
1.42
3.96
1.6
1.5
u/ml
1.6
2.1
0.23
48
392
(3007164) IgA [Mass/volume] in Serum or Plasma
190
1464
1.43
3.92
1.9
1.5
g/l
1.9
2.0
0.38
106
882
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
28
127
2.26
3.82
2.0
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
392
3429
1.39
3.75
4.6
3.1
u/l
46.0
32.7
0.86
375
3299
(3035637) Corticotropin [Mass/volume] in Plasma
21
84
2.55
3.75
1.7
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
101
694
1.54
3.68
1.3
1.2
iu/ml
19.0
20.4
0.08
26
181
(3002032) Base excess in Venous blood by calculation
74
472
1.64
3.67
14.6
6.9
mmol/l
0.9
1.5
0.63
59
381
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
459
4139
1.42
3.57
3.7
3.0
mmol/l
4.6
4.6
0.79
444
3952
(3029937) Albumin [Presence] in Urine by Test strip
150
1126
1.44
3.53
4.1
3.2
estimate
0.0
0.0
1.08
33
450
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
70
445
1.65
3.52
3.8
4.5
ng/l
237.6
813.2
0.96
54
339
(3021589) Normoblasts [#/volume] in Blood
272
2259
1.36
3.52
11.9
8.6
e9/l
0.0
0.0
0.41
221
1804
(3045414) Leukocytes [Presence] in Urine
32
159
2.07
3.51
2.0
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
26
119
2.24
3.49
1.8
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
26
122
2.18
3.30
2.5
2.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
454
4109
1.39
3.28
3.6
2.9
mmol/l
1.3
1.4
6.92
439
3915
(40761511) CBC panel - Blood by Automated count
554
5209
1.61
3.27
11.2
8.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
43
3.07
3.26
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
43
3.07
3.26
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
43
3.07
3.26
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
43
3.07
3.26
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
43
3.07
3.26
1.3
1.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
32
164
2.00
3.25
11.1
12.1
%
1.6
1.4
0.24
32
164
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
16
60
2.71
3.25
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
19
4.79
3.25
2.8
2.6
umol/l
9.4
17.3
—
9
19
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
84
572
1.54
3.19
3.4
2.8
ng/l
833.1
931.2
0.07
48
285
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
128
950
1.44
3.18
1.6
1.6
mmol/l
1.7
1.4
1.99
118
851
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
44
3.00
3.15
1.3
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
73
484
1.58
3.11
8.5
3.9
umol/l
6.5
7.1
0.11
61
399
(3001122) Ferritin [Mass/volume] in Serum or Plasma
285
2416
1.33
3.10
3.7
3.0
ug/l
66.6
71.1
0.33
271
2278
(3014051) Protein [Presence] in Urine by Test strip
19
80
2.42
3.09
2.4
1.6
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
7
12
5.88
3.03
4.3
3.3
ug/g
149.0
181.8
—
7
12
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
12
40
3.04
2.98
1.3
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
31
163
1.95
2.95
11.4
12.2
%
0.7
0.7
0.32
31
163
(3037522) Nuclear Ab [Titer] in Serum
93
660
1.48
2.91
1.6
1.4
titre
491.8
476.9
0.04
17
104
(3027945) Reticulocytes/100 erythrocytes in Blood
57
362
1.63
2.91
4.9
5.5
%
1.6
1.5
0.16
51
337
(3017143) Hepatitis C virus Ab [Presence] in Serum
137
1046
1.40
2.89
2.0
1.6
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
7
13
5.43
2.87
1.4
2.9
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
9
6.72
2.87
2.2
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
9
6.72
2.87
1.3
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
41
2.96
2.87
2.8
1.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
17
71
2.43
2.82
5.5
5.7
mmol/l
1.4
1.4
0.04
17
71
(3048689) Calprotectin [Mass/mass] in Stool
122
917
1.41
2.82
2.8
3.1
ug/g
112.3
110.5
0.03
102
733
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
18
4.49
2.80
7.0
6.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
73
497
1.53
2.78
2.2
2.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
28
146
1.96
2.74
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
176
1411
1.35
2.73
1.9
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
54
2.63
2.72
2.3
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
135
1715
0.73
2.71
1.8
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
24
3.79
2.68
1.3
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
24
3.79
2.68
1.4
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
41
244
1.73
2.67
1.7
1.6
u/ml
317.0
181.1
2.16
27
129
(3024928) Oxygen saturation in Venous blood
17
73
2.37
2.67
20.8
7.7
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
30
162
1.90
2.67
11.7
12.3
%
93.6
94.6
0.47
30
162
(44813793)
12
43
2.83
2.66
1.2
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
10
32
3.16
2.65
3.1
3.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
16
67
2.42
2.65
4.5
3.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
28
148
1.93
2.65
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
61
2.50
2.63
1.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
80
2.29
2.63
1.7
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
64
429
1.55
2.62
1.9
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
86
614
1.47
2.62
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
21
100
2.14
2.61
5.4
6.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
595
5744
1.92
2.61
22.2
13.7
e9/l
270.3
258.7
4.60
584
5592
(3028026) IgM [Mass/volume] in Serum or Plasma
51
325
1.62
2.59
2.8
1.8
g/l
1.1
1.1
0.05
45
306
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
15
62
2.45
2.55
1.0
1.1
mg/l
37.7
40.4
—
10
51
(3037756) Immunofixation for Serum or Plasma
7
16
4.41
2.48
1.0
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
28
152
1.88
2.46
1.2
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
595
5753
1.88
2.46
22.1
13.6
fl
88.4
88.5
0.22
590
5684
(3035941) MCH [Entitic mass]
595
5753
1.88
2.46
22.1
13.6
pg
29.7
29.7
0.51
590
5683
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
201
1666
1.31
2.44
3.6
2.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
595
5755
1.87
2.42
22.2
13.6
e12/l
4.7
4.7
0.79
581
5596
(3021387) Prolactin [Units/volume] in Serum or Plasma
59
396
1.54
2.42
1.4
1.6
mu/l
256.5
293.1
0.90
51
351
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
12
5.04
2.40
4.0
5.4
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
8
6.29
2.37
2.4
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
595
5758
1.86
2.37
22.2
13.7
e9/l
6.9
6.7
2.59
582
5597
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
13
52
2.53
2.37
1.5
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
595
5760
1.85
2.34
22.3
13.8
g/l
139.0
138.7
0.21
590
5684
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
133
1045
1.35
2.33
3.5
2.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
40
247
1.66
2.31
1.7
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
85
2.15
2.31
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
85
2.15
2.31
1.4
1.3
—
—
—
0
0
(4035726)
37
224
1.69
2.30
1.5
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
13
4.65
2.27
3.2
3.5
ug/l
154.2
134.8
—
6
13
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
59
402
1.52
2.27
1.9
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
47
304
1.59
2.27
1.5
1.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
25
136
1.87
2.21
5.4
4.0
nmol/l
24.6
27.2
0.57
25
131
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
24
3.36
2.18
2.3
2.6
u/ml
1611.5
703.8
—
8
24
(3006653) Thiamine [Moles/volume] in Blood
6
14
4.32
2.15
1.3
1.4
nmol/l
138.7
123.6
—
6
14
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
190
1.72
2.14
1.5
1.3
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
55
2.39
2.13
6.9
3.1
e6/l
482.5
207.9
—
8
34
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
15
68
2.24
2.12
6.3
2.9
%
9.3
10.7
—
10
53
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
198
1666
1.28
2.10
1.8
1.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
14
62
2.29
2.09
25.1
9.8
%
67.6
68.4
0.05
14
62
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
25
140
1.82
2.04
10.1
14.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
63
2.25
2.02
1.0
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
45
297
1.56
2.02
1.3
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
39
249
1.60
2.01
3.3
4.2
e9/l
65.3
68.5
0.26
31
168
(3044290) Cell count panel - Cerebral spinal fluid
22
119
1.88
1.99
3.5
2.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
57
2.31
1.99
3.4
2.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
24
134
1.82
1.98
1.8
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
21
3.36
1.97
1.9
1.3
—
—
—
0
0
(4027681)
12
51
2.38
1.96
1.3
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
14
64
2.21
1.95
6.6
3.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
11
4.57
1.94
2.0
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
27
2.99
1.94
1.1
1.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
27
2.99
1.94
1.5
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
85
2.03
1.92
1.1
1.4
ug/g
357.1
338.5
—
7
45
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
72
529
1.41
1.91
3.0
2.5
u/l
4991.2
4222.7
0.10
22
224
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
212
1816
1.25
1.91
2.8
2.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
52
360
1.49
1.89
1.9
1.9
u/l
5.5
6.8
0.92
39
282
(3011985) Renin [Units/volume] in Plasma
12
52
2.33
1.88
1.6
1.3
mu/l
42.3
52.9
0.26
12
46
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
79
2.05
1.87
1.3
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
80
2.03
1.81
1.3
1.2
—
1.1
—
0
7
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
228
1981
1.24
1.79
2.2
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
36
2.52
1.74
2.4
2.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
87
671
1.35
1.74
1.5
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
63
462
1.40
1.71
1.1
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
32
204
1.60
1.69
8.5
5.6
g/l
3.2
3.2
0.06
32
197
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
195
1677
1.24
1.66
2.7
2.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
62
2.12
1.66
10.2
13.6
u/ml
0.3
0.4
—
7
36
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
31
197
1.60
1.66
2.6
1.5
u/ml
107.9
107.3
—
8
24
(40768795) Lymph node Pathology biopsy report
7
25
2.82
1.65
1.3
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
25
2.82
1.65
4.9
7.8
—
—
—
0
0
(1002224) Polysomnography panel
32
206
1.58
1.63
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
244
2154
1.22
1.61
2.6
2.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
32
2.52
1.60
1.4
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
86
671
1.33
1.60
1.3
1.2
u/ml
1.2
6.8
3.33
29
274
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
455
0.64
1.59
1.1
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
50
2.22
1.57
2.2
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
15
3.35
1.52
3.2
4.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
31
202
1.56
1.51
4.6
3.1
umol/l
7.8
7.4
0.05
22
158
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
46
634
0.70
1.50
1.2
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
94
1.83
1.48
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
34
228
1.52
1.47
1.3
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
30
196
1.56
1.45
1.3
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
28
2.52
1.45
1.0
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
51
373
1.40
1.43
10.0
5.7
kpa
5.2
5.1
0.26
46
350
(3023511) Choriogonadotropin [Units/volume] in Urine
41
288
1.45
1.43
1.4
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
28
182
1.56
1.39
5.4
5.5
g/l
0.3
0.3
0.09
23
122
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
60
2.02
1.39
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
24
151
1.61
1.36
1.6
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
56
420
1.37
1.36
1.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
15
82
1.85
1.36
6.5
2.9
e9/l
2.1
1.2
—
10
43
(40760888) Immunoglobulin light chains.free panel - Serum
5
17
2.96
1.36
1.0
3.5
—
—
—
0
0
(3000492) Spirometry study
64
491
1.34
1.35
1.8
1.3
—
—
—
0
0
(4062490)
11
54
2.06
1.33
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
63
808
0.75
1.32
1.4
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
24
2.51
1.30
4.5
3.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
30
202
1.51
1.29
2.6
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
64
496
1.32
1.27
2.8
2.3
nmol/l
11.1
13.0
1.27
57
450
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
350
0.64
1.27
1.7
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
49
365
1.37
1.26
10.2
5.7
mmol/l
1.6
1.1
0.84
31
268
(3009445) Proteinase 3 Ab [Units/volume] in Serum
27
180
1.52
1.23
1.2
1.7
—
8.5
—
0
11
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
25
165
1.54
1.19
1.6
1.6
g/l
1.2
1.2
0.38
25
153
(44806118)
11
57
1.95
1.17
2.6
1.7
—
—
—
0
0
(44790048)
11
57
1.95
1.17
2.6
1.7
—
—
—
0
0
(44790047)
11
57
1.95
1.17
2.6
1.7
—
—
—
0
0
(44790049)
11
57
1.95
1.17
2.6
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
29
199
1.48
1.16
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
202
1801
1.18
1.14
1.5
1.7
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
12
65
1.86
1.14
1.1
1.2
u/ml
2.8
3.8
—
5
34
(3051651) Icteric interference index of Serum or Plasma
7
31
2.27
1.10
2.4
2.6
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
7
31
2.27
1.10
1.9
2.5
mmol/l
38.7
40.4
—
7
31
(3028433) Virus identified in Specimen by Culture
5
21
2.39
1.09
1.8
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
25
169
1.50
1.09
2.3
2.0
u/l
39.6
40.1
0.04
20
159
(40761536) Microorganisms panel - Urine sediment
30
418
0.70
1.09
3.1
3.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
47
358
1.34
1.07
1.9
1.8
iu/l
6.7
12.3
3.37
30
274
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
17
105
1.64
1.07
1.2
1.2
—
2.6
—
0
11
(3044941) Cell count panel - Synovial fluid
7
33
2.13
1.06
1.1
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
24
162
1.50
1.05
1.7
1.6
g/l
0.3
0.2
0.45
24
153
(40768797) Stomach Pathology biopsy report
56
440
1.30
1.04
1.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
46
1.97
1.04
2.8
2.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
18
114
1.60
1.03
1.2
1.2
—
6.3
—
0
5
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
22
2.28
1.03
1.4
2.7
ug/l
15.2
19.2
—
5
22
(3011648) Oxygen content in Venous blood
7
34
2.07
1.03
37.1
12.3
%
9.4
12.5
—
7
34
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
34
2.07
1.03
6.3
3.9
umol/l
22.1
26.4
—
7
34
(3048929) Epstein Barr virus Ab [Presence] in Serum
59
468
1.29
1.02
1.7
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
48
1.89
1.00
4.2
3.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
17
107
1.61
1.00
1.2
1.2
—
7.6
—
0
15
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
7
35
2.01
1.00
2.1
2.1
nmol/l
0.2
0.1
—
7
27
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
181
1.46
1.00
1.7
1.7
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
17
108
1.59
0.97
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
58
463
1.28
0.97
2.3
2.6
ug/l
0.9
1.3
2.36
53
428
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
50
1.81
0.97
1.2
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
34
251
1.38
0.96
1.9
1.8
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
23
158
1.47
0.95
2.1
1.9
pmol/l
219.8
225.6
0.05
23
151
(3034770) Mitochondria Ab [Titer] in Serum
23
158
1.47
0.95
1.3
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
62
1.79
0.94
1.6
2.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
45
350
1.31
0.92
2.3
2.7
%
34.4
21.8
—
7
80
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
6
28
2.15
0.91
1.3
2.0
—
41.7
—
0
5
(3009542) Hematocrit [Volume Fraction] of Blood
528
5123
1.21
0.91
18.9
10.5
%
41.0
41.0
0.12
435
4425
(3024471) HLA-A [Type]
6
29
2.08
0.89
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
40
308
1.32
0.88
13.1
5.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
30
2.01
0.87
1.5
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
31
230
1.37
0.86
1.1
1.1
u/ml
6.0
7.8
0.21
19
156
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
23
162
1.44
0.85
1.7
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
31
1.94
0.84
2.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
53
427
1.26
0.84
1.2
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
57
1.77
0.84
2.0
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
32
1.88
0.82
2.7
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
134
1187
1.16
0.82
3.7
4.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
33
1.83
0.79
1.5
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
26
0.00
0.78
0.0
2.2
—
7.5
—
0
20
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
34
1.77
0.76
1.7
1.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
53
1.71
0.75
1.1
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
53
1.71
0.75
1.6
1.6
—
—
—
0
0
(3013512) EKG study
85
730
1.19
0.75
2.8
2.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
24
2.09
0.74
1.4
7.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
38
1.85
0.73
2.4
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
38
1.85
0.73
1.1
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
40
1.76
0.71
1.3
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
26
1.93
0.70
2.2
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.6
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
41
1.72
0.70
1.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
61
1.65
0.69
2.1
3.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
27
1.86
0.68
2.2
2.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
39
312
1.27
0.68
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
98
861
1.16
0.68
3.4
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
28
1.79
0.66
1.4
3.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
28
1.79
0.66
1.4
3.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
55
460
1.21
0.66
1.2
1.3
iu/ml
94.2
139.1
0.41
14
167
(3020393) Adenovirus Ag [Presence] in Stool
5
30
1.67
0.61
3.8
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
22
0.00
0.59
0.0
7.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.3
—
2.5
—
0
8
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
72
1.54
0.59
2.8
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
11
72
1.54
0.59
3.0
2.0
ug/l
1.0
5.0
0.55
11
67
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.59
2.3
2.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
32
256
1.26
0.58
1.2
1.2
u/ml
6.6
1.6
0.78
19
135
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
35
1.72
0.58
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
35
1.72
0.58
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
132
1.37
0.57
1.5
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
36
1.67
0.57
3.0
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
19
142
1.35
0.55
1.1
1.1
u/ml
7.6
7.3
—
10
73
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
60
1.51
0.54
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
66
574
1.17
0.54
1.7
2.0
—
—
—
0
0
(3019225) pH of Specimen
32
259
1.25
0.53
4.0
3.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
66
1.52
0.53
1.7
1.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
96
0.62
0.52
2.5
4.0
%
44.5
52.8
—
6
96
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
96
0.62
0.52
2.5
3.7
e9/l
2.5
3.6
—
6
96
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
27
336
0.79
0.52
3.0
2.7
%
31.0
31.1
0.01
21
244
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
1.0
1.1
mg/l
272.2
294.1
—
6
34
(3003181) Sodium [Moles/volume] in Urine
7
45
1.56
0.49
1.9
3.4
mmol/l
80.4
80.9
—
7
39
(3008401) Mugwort IgE Ab [Units/volume] in Serum
28
227
1.24
0.47
1.1
1.1
u/ml
1.8
1.4
0.12
16
136
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
113
1235
0.90
0.47
1.6
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
23
182
1.27
0.47
1.2
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
12
165
0.72
0.47
1.4
2.1
u/ml
20.9
28.7
0.64
12
156
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
50
1.40
0.45
1.6
1.4
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
7
50
1.40
0.45
8.3
7.4
g/mol
38.1
53.1
—
7
44
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
121
1.33
0.44
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
15
113
1.34
0.43
1.3
1.1
u/ml
5.0
2.7
—
8
53
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
32
1.57
0.42
1.0
1.2
iu/ml
142.0
227.2
—
5
32
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
57
1.41
0.42
3.3
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
33
1.52
0.41
1.8
2.5
mmol/l
9.0
6.7
—
5
33
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
14
105
1.34
0.41
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.8
—
1.7
—
0
15
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.6
—
1.2
—
0
16
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
43
371
1.17
0.41
1.7
1.5
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
17
132
1.30
0.40
1.1
1.1
—
9.7
—
0
10
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
18
0.00
0.40
0.0
2.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
26
313
0.82
0.40
4.0
4.7
%
0.0
0.0
—
9
71
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
10.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
58
516
1.14
0.38
1.3
1.4
—
—
—
0
0
(4034850)
8
114
0.70
0.37
10.6
6.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
30
353
0.84
0.37
1.9
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
9
70
1.29
0.36
6.0
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
81
1.36
0.36
2.1
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
20
162
1.24
0.36
1.2
1.0
u/ml
4.9
5.5
—
10
73
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
154
1.24
0.34
1.6
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
487
4953
0.92
0.34
4.2
3.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
33
381
0.86
0.33
1.5
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
1.8
1.4
nmol/l
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
101
1.29
0.32
2.8
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
124
1318
0.93
0.30
2.9
2.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
93
1.30
0.30
1.7
1.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
19
157
1.22
0.30
1.3
1.3
—
1.3
—
0
8
(3002179) Metamyelocytes/100 leukocytes in Blood
27
313
0.86
0.29
3.8
4.3
%
0.0
0.5
—
7
64
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
28
241
1.17
0.29
2.1
1.8
nmol/l
30.6
35.7
0.65
28
236
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
110
0.72
0.29
2.1
2.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
16
130
1.24
0.29
3.3
4.1
ug/l
2.6
7.8
—
9
94
(3017732) Neutrophils [#/volume] in Blood
34
299
1.15
0.28
4.9
1.9
e9/l
3.9
4.1
0.28
28
267
(3010726) Horse dander IgE Ab [Units/volume] in Serum
27
233
1.17
0.28
1.1
1.1
u/ml
1.8
3.2
—
10
62
(4268621)
8
63
1.27
0.28
2.0
2.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
37
328
1.14
0.27
1.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
120
0.75
0.27
2.1
2.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
13
104
1.26
0.26
1.5
1.4
u/l
14.4
12.6
0.09
13
91
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
67
1.20
0.26
1.1
1.1
—
—
—
0
0
(4306422)
9
77
1.17
0.24
1.1
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
36
322
1.13
0.24
1.4
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
152
1.19
0.24
1.1
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
5
38
1.32
0.23
4.8
3.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
11
88
1.25
0.22
1.2
1.4
u/ml
2.6
3.5
—
5
44
(3041806) Other cells [#/volume] in Blood by Manual count
7
91
0.77
0.22
2.0
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
153
1.18
0.22
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
17
144
1.19
0.22
1.2
1.0
u/ml
0.1
0.6
—
6
42
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
42
1.19
0.21
3.0
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
42
1.19
0.21
1.2
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.4
—
32250.0
—
0
6
(40768806) Pleura Pathology biopsy report
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
8.1
—
0
13
(3023199) Leukocytes [#/volume] in Pleural fluid
0
13
0.00
0.21
0.0
1.3
—
4096.9
—
0
8
(3044927) Protein electrophoresis panel - Urine
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
30
334
0.89
0.20
1.7
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
48
1.25
0.20
2.2
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4094501)
6
50
1.20
0.19
1.2
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
1.2
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
53
1.13
0.18
2.3
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
7
58
1.21
0.18
4.0
3.4
u/ml
7.4
53.4
—
7
45
(3019832) Treponema pallidum Ab [Presence] in Serum
149
1438
1.05
0.17
2.0
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
66
0.76
0.17
1.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
20
177
1.13
0.16
1.4
1.3
ug/l
2.9
4.1
0.93
20
165
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
72
1.11
0.16
1.9
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
102
1.18
0.15
2.7
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
93
1.19
0.14
1.5
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
35
324
1.09
0.14
1.4
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
84
1.19
0.14
1.7
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
24
218
1.10
0.14
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
38
407
0.93
0.13
1.4
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
30
322
0.93
0.11
3.9
4.6
%
0.1
0.1
0.20
12
84
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
144
1.11
0.10
1.4
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
31
331
0.93
0.10
3.9
4.7
%
0.5
0.8
0.47
12
87
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
36
339
1.07
0.10
1.5
1.3
miu/ml
258.7
258.0
0.00
14
169
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
77
798
0.96
0.10
1.4
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
2.6
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
45
1.11
0.10
1.0
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
13
116
1.12
0.09
1.2
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
48
1.04
0.09
1.0
4.6
—
102.4
—
0
15
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
56
1.07
0.08
3.7
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
29
308
0.94
0.08
1.3
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
30
283
1.06
0.08
2.6
2.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
39
409
0.95
0.08
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
39
409
0.95
0.08
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
39
409
0.95
0.08
1.4
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
66
1.06
0.08
2.6
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
98
1.12
0.07
1.8
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
174
0.92
0.07
1.6
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
94
917
1.03
0.07
1.6
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
91
0.88
0.07
1.8
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
217
1.06
0.06
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
129
0.93
0.03
1.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
14
149
0.94
0.03
2.0
1.8
iu/l
4.2
5.4
—
6
57
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
102
1.08
0.03
3.8
2.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
123
0.98
0.00
1.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
147
1.02
0.00
1.5
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
45
449
1.00
0.00
1.4
1.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
69
0.87
0.00
7.3
5.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
69
0.87
0.00
3.7
2.6
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
9
0.00
0.00
0.0
15.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
90
1.00
0.00
1.1
1.1
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
9
0.00
0.00
0.0
1.1
—
481.1
—
0
9
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
7
69
1.01
0.00
1.0
1.6
—
11.5
—
0
11
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.5
—
4.2
—
0
6
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
91
0.99
0.00
1.6
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
4.8
—
0.3
—
0
6
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
0.4
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
10.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
8
0.00
0.00
0.0
7.1
—
17.0
—
0
8
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
2.6
—
0.3
—
0
5
(40765089) Chromosome analysis panel - Blood by G-banded
6
64
0.94
0.00
1.0
1.1
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
14.8
—
46.7
—
0
6
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
1.4
—
0
5
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
69
1.01
0.00
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
50
1.00
0.00
1.6
1.3
—
—
—
0
0
(44806071)
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
14.5
—
0
5
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
285.2
—
0
6
(3045424) Erythrocytes [Presence] in Urine
6
67
0.89
0.00
1.7
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
26
260
1.00
0.00
1.8
1.9
ug/l
0.4
0.6
1.56
14
95
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: F5_READING – Disorders in reading
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).